<DOC>
	<DOC>NCT02100202</DOC>
	<brief_summary>The purpose of this study is to investigate the efficacy and safety of dietary supplements (BioTurmin, BioTurmin-WD and MaQxan) on cotinine level and oxidative stress marker in chronic smokers having mild to moderate hyperlipidemia after 30 days of intervention.</brief_summary>
	<brief_title>Efficacy and Safety Study of Dietary Supplements in Chronic Smokers Having Mild to Moderate Hyperlipidemia</brief_title>
	<detailed_description>In a randomized, double-blind, placebo control trial, the efficacy and safety of dietary supplements (BioTurmin, BioTurmin-WD and MaQxan) will be investigated in chronic smokers having mild to moderate hyperlipidemia. Sixty subjects will be randomly assigned to receive the dietary supplements and placebo for 30 days. The efficacy of the supplements will be measured by estimating cotinine and malondialdehyde level.</detailed_description>
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Turmeric extract</mesh_term>
	<criteria>Men &gt; 20 years Chronic cigarette/ beedi smoker (23 packets/day since last 3 years or more) with mild to moderate hyperlipidemia (LDL ranging 160189 mg/dL, TC &gt;200 mg/dL and/or HDLC &lt;40 mg/dL) Being mentally competent and able to understand all study requirements and sign the informed consent form. Patients with Chronic obstructive pulmonary disease (COPD) Women Patients with severe liver, renal, cardiac or brain diseases. Unable to complete follow up. Subjects on any medication like diuretics. Allergic to any medication. With a history of alcohol and/or drug abuse.</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Dietary supplements</keyword>
	<keyword>Cotinine level</keyword>
	<keyword>Malondialdehyde</keyword>
	<keyword>Chronic smokers</keyword>
	<keyword>Hyperlipidemia</keyword>
</DOC>